Renovaro Biosciences
Price & Volume
Stats
See more52W Range | $0.39-$5.25 |
Market Cap | $260.2M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.98 |
News
See moreYahoo Finance • last year
Avram Miller, Co-Founder of Intel Capital, Joins Renovaro Biosciences Board of Directors
Yahoo Finance • last year
Renovaro Biosciences Appoints Two Finance Industry Experts to Board of Directors
Yahoo Finance • last year
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PNT, RENB, KITT, APRN
Yahoo Finance • last year
Message from Renovaro Biosciences CEO, The Hon. Mark Dybul, MD
About
CEO | Mr. David H. Weinstein |
Address | 2080 Century Park East, Los Angeles, CA, United States, 90067 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 25 |
